Form 8-K Summary
Registrant: Tivic Health Systems, Inc. The request metadata identifies Valion Bio, Inc., but the filing names Tivic Health Systems, Inc. as the registrant.
Report date: July 5, 2023; filed July 6, 2023. The filing reports a corporate governance amendment rather than financial results.
Business Context and Reporting Period
Tivic Health Systems, Inc. is a Delaware corporation whose common stock trades on Nasdaq under the symbol TIVC. The filing was made under Item 5.03 of Form 8-K to report amendments to the Company’s Amended and Restated Bylaws.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes
- On July 5, 2023, the Company amended its Bylaws through a Certificate of Amendment.
- Article II, Section 2.5 was revised to incorporate requirements under SEC Rule 14a-19 concerning shareholder solicitation procedures.
- Article II, Section 2.8 was revised to reduce the quorum requirement for shareholder meetings to one-third of the capital stock issued and outstanding and entitled to vote at the meeting.
- Shareholder approval was not required under Article XI of the Bylaws.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance, business outlook, management commentary, contingencies, or unusual financial items. The principal governance implication is that future shareholder meetings may be conducted with a lower quorum threshold, subject to the full text of the amended Bylaws.
Important Facts to Verify
- Review Exhibit 3.1 for the complete language of the Certificate of Amendment and the precise Rule 14a-19 provisions incorporated into the Bylaws.
- Confirm the application of the one-third quorum threshold to future shareholder meetings.
- Confirm the registrant identity, because the supplied metadata names Valion Bio, Inc., while the filing names Tivic Health Systems, Inc.
- Verify that no separate financial disclosures or material events were filed concurrently, as this 8-K contains no financial statements or operating metrics.